121 related articles for article (PubMed ID: 1732132)
1. Opposite effects of cholestyramine and loxiglumide on gallbladder dynamics in humans.
Palasciano G; Portincasa P; Belfiore A; Baldassarre G; Albano O
Gastroenterology; 1992 Feb; 102(2):633-9. PubMed ID: 1732132
[TBL] [Abstract][Full Text] [Related]
2. Endogenous cholecystokinin enhances postprandial gastroesophageal reflux in humans through extrasphincteric receptors.
Clavé P; González A; Moreno A; López R; Farré A; Cussó X; D'Amato M; Azpiroz F; Lluís F
Gastroenterology; 1998 Sep; 115(3):597-604. PubMed ID: 9721157
[TBL] [Abstract][Full Text] [Related]
3. Effect of cholestyramine and cholecystokinin receptor antagonist CR1505 (loxiglumide) on lower esophageal sphincter pressure in man.
Masclee AA; Jansen JB; Rovati LC; Lamers CB
Dig Dis Sci; 1993 Oct; 38(10):1889-92. PubMed ID: 8404410
[TBL] [Abstract][Full Text] [Related]
4. Dose-response effects of oral loxiglumide on postprandial gall-bladder emptying in man.
Malesci A; De Fazio C; Festorazzi S; Bonato C; Valentini A; Tacconi M; Bekkering M; Giacovelli G; D'Amato M; Rovati LC
Arzneimittelforschung; 1992 Nov; 42(11):1359-62. PubMed ID: 1492852
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of gallbladder emptying in gallstone patients after oral cholestyramine.
Portincasa P; Di Ciaula A; Palmieri VO; Baldassarre G; Palasciano G
Am J Gastroenterol; 1994 Jun; 89(6):909-14. PubMed ID: 8198104
[TBL] [Abstract][Full Text] [Related]
6. Effect of a cholecystokinin receptor antagonist (loxiglumide) on gallbladder contractile function in guinea pigs.
Tsubo K; Arai M; Omachi H; Mitamura K
J Gastroenterol; 1996 Aug; 31(4):578-81. PubMed ID: 8844481
[TBL] [Abstract][Full Text] [Related]
7. Effects of loxiglumide on gallbladder emptying in healthy volunteers.
Niederau C; Heintges T; Rovati L; Strohmeyer G
Gastroenterology; 1989 Nov; 97(5):1331-6. PubMed ID: 2792664
[TBL] [Abstract][Full Text] [Related]
8. Effects of cholestyramine on gallbladder and gastric emptying in obese and lean subjects.
Portincasa P; Di Ciaula A; Palmieri V; Van Berge-Henegouwen GP; Palasciano G
Eur J Clin Invest; 1995 Oct; 25(10):746-53. PubMed ID: 8557061
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of loxiglumide (CCK antagonist) inhibits postprandial gallbladder contraction without affecting gastric emptying.
Corazziari E; Ricci R; Biliotti D; Bontempo I; De Medici A; Pallotta N; Torsoli A
Dig Dis Sci; 1990 Jan; 35(1):50-4. PubMed ID: 2295294
[TBL] [Abstract][Full Text] [Related]
10. Cholestyramine influences meal-stimulated pancreaticobiliary function and plasma cholecystokinin independent of gastric emptying and food digestion.
Thimister PW; Hopman WP; Loualidi A; Rosenbusch G; Willems HL; Trijbels FJ; Jansen JB
Scand J Gastroenterol; 1997 Aug; 32(8):778-84. PubMed ID: 9282969
[TBL] [Abstract][Full Text] [Related]
11. Effect of cholecystokinin-A receptor blockade on postprandial insulinaemia and gastric emptying in humans.
Hidalgo L; Clavé P; Estorch M; Rodríguez-Espinosa J; Rovati L; Greeley GH; Capellà G; Lluís F
Neurogastroenterol Motil; 2002 Oct; 14(5):519-25. PubMed ID: 12358680
[TBL] [Abstract][Full Text] [Related]
12. Physiological role of cholecystokinin on postprandial insulin secretion and gastric meal emptying in man. Studies with the cholecystokinin receptor antagonist loxiglumide.
Fried M; Schwizer W; Beglinger C; Keller U; Jansen JB; Lamers CB
Diabetologia; 1991 Oct; 34(10):721-6. PubMed ID: 1959704
[TBL] [Abstract][Full Text] [Related]
13. Effects of cholecystokinin-receptor blockade on pancreatic and biliary function in healthy volunteers.
Schwarzendrube J; Niederau M; Lüthen R; Niederau C
Gastroenterology; 1991 Jun; 100(6):1683-90. PubMed ID: 2019374
[TBL] [Abstract][Full Text] [Related]
14. Effect of loxiglumide on gallbladder contractile response to cerulein and food in humans.
Malesci A; De Fazio C; Festorazzi S; Bonato C; Valentini A; Tacconi M; Rovati L; Setnikar I
Gastroenterology; 1990 May; 98(5 Pt 1):1307-10. PubMed ID: 2323521
[TBL] [Abstract][Full Text] [Related]
15. The role of cholecystokinin and the cholinergic system in intravenous amino acid-induced gallbladder emptying.
Gielkens HA; de Boer SY; Lam WF; Rovati LC; Lamers CB; Masclee AA
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1227-31. PubMed ID: 9471030
[TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR
Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin antagonistic activities of loxiglumide.
Wakatsuki K; Saito T; Saeki M; Ninomiya K; Kasai H; Kimura K; Fujii M
Arzneimittelforschung; 1997 Oct; 47(10):1130-3. PubMed ID: 9368707
[TBL] [Abstract][Full Text] [Related]
18. Acute intraduodenal bile salt depletion leads to strong gallbladder contraction, altered antroduodenal motility and high plasma motilin levels in humans.
Portincasa P; Peeters TL; van Berge-Henegouwen GP; van Solinge WW; Palasciano G; van Erpecum KJ
Neurogastroenterol Motil; 2000 Oct; 12(5):421-30. PubMed ID: 11012942
[TBL] [Abstract][Full Text] [Related]
19. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR
Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of cholecystokinin and pancreaticobiliary response to intraduodenal bile acids and cholestyramine in humans.
Koop I; Dorn S; Koop H; Witzleb S; Beglinger C; Schafmayer A; Arnold R
Dig Dis Sci; 1991 Nov; 36(11):1625-32. PubMed ID: 1935502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
